22-30007315-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000401950.7(MTMR3):c.873G>T(p.Glu291Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000479 in 1,461,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000401950.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTMR3 | NM_021090.4 | c.873G>T | p.Glu291Asp | missense_variant | 10/20 | ENST00000401950.7 | NP_066576.1 | |
MTMR3 | NM_153050.3 | c.873G>T | p.Glu291Asp | missense_variant | 10/20 | NP_694690.1 | ||
MTMR3 | NM_153051.3 | c.873G>T | p.Glu291Asp | missense_variant | 10/19 | NP_694691.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTMR3 | ENST00000401950.7 | c.873G>T | p.Glu291Asp | missense_variant | 10/20 | 1 | NM_021090.4 | ENSP00000384651 | P4 | |
ENST00000624945.1 | n.20922C>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1461632Hom.: 0 Cov.: 30 AF XY: 0.00000550 AC XY: 4AN XY: 727104
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 16, 2023 | The c.873G>T (p.E291D) alteration is located in exon 10 (coding exon 8) of the MTMR3 gene. This alteration results from a G to T substitution at nucleotide position 873, causing the glutamic acid (E) at amino acid position 291 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at